$0.9201
-0.0799-7.99%
OS Therapies Inc
OSTXAMEX
The average analyst price target for OS Therapies is $15.20. Of 5 analysts, 5 rate it Buy. Targets range from $7 to $21. The latest change came on Jul 9, 2026, when Roth Capital initiated coverage of OS Therapies with a Buy rating and a $7 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
